News and insights into the #2 pharma/medtech market - China

Greg B. Scott founded ChinaBio® in 2007 to help western life science companies achieve success in China. ChinaBio® is a consulting and advisory firm based in Shanghai that has helped over 100 U.S., European and APAC companies seeking partnerships, acquisitions, novel ... more

ALL CONTRIBUTIONS

Week In Review: CStone's Hong Kong IPO To Raise $304 Million At $1.5 Billion Valuation Next Week
China will reduce the Value Added Tax on 21 rare disease treatments to 3%, starting March 1. Plus: an IPO, financings, licensing, funding rounds.
Read
Week In Review: China Resources And Charoen Pokphand Join To Launch $300 Million Life Science Fund
This week in Chinese biotech: new funding sources, startups funded, licensing news, trials and approvals.
Read
Week In Review: New Shanghai Hi-Tech Exchange To IPO Pre-Revenue Companies
The Shanghai Stock Exchange's new Technology Innovation Board will allow still-unprofitable hi-tech companies - including biopharmas - to IPO on the exchange, though each company that debuts must have a valuation of at least $600 million to qualify.
Read
Week In Review: China Green Lights Nasdaq-Style Exchange For Young Companies
China has given the green light to a new registration-based Shanghai stock exchange aimed at high tech companies that will be less regulated than other China exchanges. The new exchange resembles Nasdaq with its dealer-to-dealer pricing mechanism.
Read
Week In Review: Yantai's MabPlex Raises $59 Million To Expand CDMO Services
MabPlex, a biologics CDMO, raised $59 million in a Series A round from SDIC Venture Fund and Shenzhen Venture Capital. MabPlex offers biologics development and manufacturing services, including mAbs, recombinant proteins, ADCs and bispecifics.
Read
Week In Review: China Life Science Starts Off 2019 With $425 Million In Deals
China's life science sector started off 2019 with $425 million from ten deals involving Apollomics, Schrödinger of New York City and BrightGene Bio-Medical of Suzhou, among others.
Read

STOCKS I FOLLOW

AXN Aoxing Pharmaceutical Company, Inc.
CRPNF China Pioneer Pharma Holdings Ltd.
CYIG CHINA YCT INTL GROUP
HCM Hutchison Chi-Med
ICLR Icon PLC
MCRPF MICROPORT SCIENTIFIC
MDCO The Medicines Company
MR Mindray Medical International Limited
NBY NovaBay Pharmaceuticals, Inc.
SCLN SciClone Pharmaceuticals, Inc.
WX WuXi PharmaTech Inc.
Load More

TWEETS

LATEST ACTIVITY

ChinaBio® Today
Week In Review: New Shanghai Hi-Tech Exchange To IPO Pre-Revenue Companies https://t.co/iT2LDGqyGt
ChinaBio® Today
Week In Review: China Green Lights Nasdaq-Style Exchange For Young Companies $CIR $CIR $BABA $KANG $TCON https://t.co/BuSpeVe3jP less
ChinaBio® Today
Week In Review: Yantai's MabPlex Raises $59 Million To Expand CDMO Services $AZN $AZN $IRWD $CBMG $BGNE https://t.co/NWU5BAPlTw less
All Posts

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications